Biomarker Directed Treatment in Metastatic Colorectal Cancer

NCT01703390 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: FOLFIRI + Cetuximab
DRUG: modifiedFOLFOX6 + Cetuximab

Sponsor

Arbeitsgemeinschaft medikamentoese Tumortherapie

Collaborators

[object Object]